Your browser doesn't support javascript.
loading
BRCA1 and BRCA2 whole cDNA analysis in unsolved hereditary breast/ovarian cancer patients.
Montalban, Gemma; Bonache, Sandra; Bach, Vanessa; Gisbert-Beamud, Alexandra; Tenés, Anna; Moles-Fernández, Alejandro; López-Fernández, Adrià; Carrasco, Estela; Balmaña, Judith; Diez, Orland; Gutiérrez-Enríquez, Sara.
Afiliação
  • Montalban G; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Office 4.08, Cellex Center, c/ Natzaret, 115-117, 08035 Barcelona, Spain.
  • Bonache S; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Office 4.08, Cellex Center, c/ Natzaret, 115-117, 08035 Barcelona, Spain.
  • Bach V; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Office 4.08, Cellex Center, c/ Natzaret, 115-117, 08035 Barcelona, Spain.
  • Gisbert-Beamud A; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Office 4.08, Cellex Center, c/ Natzaret, 115-117, 08035 Barcelona, Spain.
  • Tenés A; Area of Clinical and Molecular Genetics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Moles-Fernández A; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Office 4.08, Cellex Center, c/ Natzaret, 115-117, 08035 Barcelona, Spain.
  • López-Fernández A; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Office 4.08, Cellex Center, c/ Natzaret, 115-117, 08035 Barcelona, Spain.
  • Carrasco E; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Office 4.08, Cellex Center, c/ Natzaret, 115-117, 08035 Barcelona, Spain.
  • Balmaña J; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Office 4.08, Cellex Center, c/ Natzaret, 115-117, 08035 Barcelona, Spain; Medical Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus,
  • Diez O; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Office 4.08, Cellex Center, c/ Natzaret, 115-117, 08035 Barcelona, Spain; Area of Clinical and Molecular Genetics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospi
  • Gutiérrez-Enríquez S; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Office 4.08, Cellex Center, c/ Natzaret, 115-117, 08035 Barcelona, Spain. Electronic address: sgutierrez@vhio.net.
Cancer Genet ; 258-259: 10-17, 2021 11.
Article em En | MEDLINE | ID: mdl-34237702
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: DNA Complementar / Proteína BRCA1 / Predisposição Genética para Doença / Proteína BRCA2 / Síndrome Hereditária de Câncer de Mama e Ovário / Mutação Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: DNA Complementar / Proteína BRCA1 / Predisposição Genética para Doença / Proteína BRCA2 / Síndrome Hereditária de Câncer de Mama e Ovário / Mutação Idioma: En Ano de publicação: 2021 Tipo de documento: Article